Table 1 Summary of IC50 values for 10 drugs derived from single-drug dose-response assays in 10 CRC PDO lines
Drug | Average IC50 (µM) | CRC PDO Average IC50 (µM) | Cmax (µM) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
ptCRC04 | ptCRC07 | mCRC07 | ptCRC08 | mCRC08 | ptCRC09 | ptCRC11 | mCRC11 | ptCRC13 | mCRC16 | |||
5-fluorouracil | 8.66 ± 8.32 | 36.72 ± 15.1 | 18.54 ± 13.18 | 11.62 ± 4.05 | 69.63 ± 47.43 | 1.09 ± 0.23 | 194 ± 32.13 | 17.94 ± 9.58 | 46.51 ± 25.44 | 127.57 ± 24.1 | 53.23 | 426 |
Oxaliplatin | 8.85 ± 5.9 | 24.55 ± 13.58 | 10.97 ± 1.36 | 2.62 ± 1.67 | 22.11 ± 9.78 | 1.04 ± 1.18 | 120.97 ± 32.18 | 10.28 ± 1.79 | 37.15 ± 22.62 | 14.26 ± 9.33 | 25.28 | 4.96 |
Leucovorin | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | 2.86 |
SN-38 | 0.00528 ± 0.00071 | 0.01656 ± 0.01551 | 0.00514 ± 0.0026 | 0.008 ± 0.002 | 0.2806 ± 0.19554 | 0.0059 ± 0.0003 | 0.37023 ± 0.03774 | 0.13 ± 0.18 | 0.16982 ± 0.16458 | 0.4289 ± 0.29754 | 0.14204 | 0.143 |
Regorafenib | 8.66 ± 4.34 | 7.23 ± 4.83 | 2.64 ± 0.28 | 2.24 ± 0.98 | 2.24 ± 0.28 | 5.4 ± 3.25 | 9.34 ± 2.89 | 3.78 ± 1.05 | 7.85 ± 3.67 | 6.42 ± 4.47 | 5.58 | 8.08 |
Pemrametostat | 285.2 ± 156 | 214.87 ± 169.81 | 5.61 ± 3.22 | 67.99 ± 46.55 | 89.82 ± 53.4 | 42.75 ± 35.17 | N.D. | N.D. | 160.15 ± 98.28 | N.D. | 123.77 | 3.54 |
TP-064 | 18.06 ± 9.02 | 8.38 ± 3.34 | 3.05 ± 1.05 | 15.83 ± 4.13 | 24.02 ± 5.95 | 10.72 ± 0.57 | 22.6 ± 13.02 | 6.92 ± 3.18 | 47.15 ± 11.18 | 38.14 ± 5.38 | 19.49 | – |
Decitabine | 2.26 ± 2.43 | 48.17 ± 38.73 | 25.98 ± 16.58 | 133 ± 110.65 | 207.93 ± 16.46 | 18.53 ± 25.67 | 149.92 ± 122.97 | 251.88 ± 170.47 | 395.33 ± 252.84 | N.D. | 113.62 | 0.323 |
Entinostat | 2.29 ± 1.79 | 3.17 ± 1.43 | 28.7 ± 1.41 | 1.11 ± 0.06 | 1.26 ± 0.3 | 0.73 ± 0.31 | 0.73 ± 0.12 | 5.26 ± 2.97 | 3.19 ± 1.09 | 1.51 ± 0.24 | 4.80 | 0.19 |
Vorinostat | 0.67 ± 0.32 | 1.85 ± 0.7 | 1.27 ± 0.23 | 0.998 ± 0.179 | 0.63 ± 0.28 | 1.01 ± 1.46 | 1.07 ± 0.35 | 2.75 ± 1.19 | 1.43 ± 0.42 | 0.24 ± 0.08 | 1.19 | 1.2 |